Clinical Trials Browser

Phase 2 × Leukemia, Promyelocytic, Acute × Bortezomib × Clear all

NCT01465386 2017-04-04

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Phase 2 Terminated

6 enrolled 8 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

NCT01950611 2013-09-25

PIAPL

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute